Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma

Masashi Koto, Azusa Hasegawa, Ryo Takagi, Go Sasahara, Hiroaki Ikawa, Jun Etsu Mizoe, Keiichi Jingu, Hirohiko Tsujii, Tadashi Kamada, Yoshitaka Okamoto

研究成果: Article査読

28 被引用数 (Scopus)


Background and purpose: To evaluate the safety and efficacy of carbon ion radiotherapy (CIRT) for locally advanced sinonasal adenocarcinoma. Material and methods: Twenty-two patients with sinonasal adenocarcinoma were treated with CIRT. CIRT was the primary treatment for 16 patients. Four patients received CIRT for local recurrence after surgery and two for residual tumour after surgery or chemotherapy. At the start of CIRT, 1 patient had T-classification (T) 2 disease, 2 had T3 disease, 5 had T4a disease, and 14 had T4b disease. Fourteen patients were treated with 57.6 Gy equivalent (GyE)/16 fractions, and 8, with 64.0 GyE/16 fractions. Results: The median follow-up period was 43 months for all patients. The 3-year local control and locoregional control rates for all patients were 76.9% (95% confidence interval [CI] = 56.7-97.1%) and 61.3% (95% CI = 38.5-84.1%), respectively. The 3-year overall survival and disease-specific survival rates were 59.1% (95% CI = 38.6-79.6%) and 65.6% (95% CI = 44.9-86.3%), respectively. Acute reactions of grade 3 of the skin and mucosa were observed in 2 and 4 patients, respectively. Late reactions included lateral visual loss (5 patients), mucosal ulceration (1 patient), and brain necrosis with clinical symptoms (1 patient). In the 5 patients who developed visual loss, the optic nerve was close to the tumour. Conclusions: CIRT was effective and generally safe for locally advanced sinonasal adenocarcinoma.

ジャーナルRadiotherapy and Oncology
出版ステータスPublished - 2014

ASJC Scopus subject areas

  • 血液学
  • 腫瘍学
  • 放射線学、核医学およびイメージング


「Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。